Shulph Ink
A review of PAP therapy for the treatment of OSA, An Issue of Sleep Medicine Clinics
A review of PAP therapy for the treatment of OSA, An Issue of Sleep Medicine Clinics
YOU SAVE £6.81
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about A review of PAP therapy for the treatment of OSA, An Issue of Sleep Medicine Clinics
The article discusses the use of positive airway pressure (PAP) therapy for the treatment of obstructive sleep apnea (OSA). PAP is the preferred treatment for moderate-to-severe OSA, and randomized controlled trials have shown it to effectively reduce apnea-hypopnea index and improve sleepiness. The article includes an up-to-date review of PAP therapy, with 14 practice-oriented topics covered, such as racial differences in PAP adherence, cost-benefit analysis of CPAP vs other treatments, best predictors of PAP compliance, and the effect of insomnia on OSA treatment. The reviews are written by top experts in the field and provide actionable insights for clinical practice.
Format: Hardback
Length: 240 pages
Publication date: 08 November 2022
Publisher: Elsevier - Health Sciences Division
Dr. Matthew R. Ebben, a renowned expert in the field of sleep medicine, takes the helm as guest editor in this issue of Sleep Medicine Clinics, delving into the realm of Positive Airway Pressure (PAP) Therapy for the Treatment of Obstructive Sleep Apnea (OSA). PAP emerges as the preferred treatment option for patients with moderate-to-severe OSA, backed by robust evidence from randomized controlled trials. These trials have conclusively demonstrated that PAP can effectively reduce the apnea-hypopnea index, thereby improving both subjective and objective sleepiness.
In this comprehensive issue, esteemed experts offer an up-to-date review of PAP therapy, encompassing 14 practice-oriented topics. These topics range from racial differences in PAP adherence to the cost-benefit analysis of CPAP versus alternative treatments for OSA. They also delve into the best predictors of PAP compliance, exploring the impact of insomnia on OSA treatment, as well as cognitive complaints and comorbidities commonly associated with this condition.
Furthermore, the issue provides in-depth clinical reviews on PAP therapy, offering actionable insights for clinical practice. Authored by esteemed experts in the field, these reviews synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. By presenting the latest information on this timely and focused topic, under the guidance of experienced editors, this issue serves as a valuable resource for healthcare professionals seeking to enhance their understanding and expertise in the treatment of OSA.
Weight: 438g
Dimension: 185 x 263 x 13 (mm)
ISBN-13: 9780323987899
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
